Chemotherapy of colorectal liver metastases induces a rapid rise in intermediate blood monocytes which predicts treatment response

References

• Murdoch C, Muthana M, Coffelt SB, Lewis CE. The role of myeloid cells in the promotion of tumour angiogenesis. Nat Rev Cancer 2008; 8:618-31; PMID:18633355; http://dx.doi.org/10.1038/nrc2444
   PubMed Web of Science ®Google Scholar
• Yamashiro S, Takeya M, Nishi T, Kuratsu J, Yoshimura T, Ushio Y, Takahashi K. Tumor-derived monocyte chemoattractant protein-1 induces intratumoral infiltration of monocyte-derived macrophage subpopulation in transplanted rat tumors. Am J Pathol 1994; 145:856-67; PMID:7943176;
   PubMed Web of Science ®Google Scholar
• Murdoch C, Giannoudis A, Lewis CE. Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. Blood 2004; 104:2224-34; PMID:15231578; http://dx.doi.org/10.1182/blood-2004-03-1109
   PubMed Web of Science ®Google Scholar
• Leek RD, Lewis CE, Whitehouse R, Greenall M, Clarke J, Harris AL. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res 1996; 56:4625-9; PMID:8840975
   PubMed Web of Science ®Google Scholar
• Lissbrant IF, Stattin P, Wikstrom P, Damber JE, Egevad L, Bergh A. Tumor associated macrophages in human prostate cancer: relation to clinicopathological variables and survival. Int J Oncol 2000; 17:445-51; PMID:10938382; http://dx.doi.org/10.3892/ijo.17.3.445
   PubMed Web of Science ®Google Scholar
• Zhu XD, Zhang JB, Zhuang PY, Zhu HG, Zhang W, Xiong YQ, Wu WZ, Wang L, Tang ZY, Sun HC. High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma. J Clin Oncol 2008; 26:2707-16; PMID:18509183; http://dx.doi.org/10.1200/JCO.2007.15.6521
   PubMed Web of Science ®Google Scholar
• Dong Z, Kumar R, Yang X, Fidler IJ. Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma. Cell 1997; 88:801-10; PMID:9118223; http://dx.doi.org/10.1016/S0092-8674(00)81926-1
   PubMed Web of Science ®Google Scholar
• Tsung K, Dolan JP, Tsung YL, Norton JA. Macrophages as effector cells in interleukin 12-induced T cell-dependent tumor rejection. Cancer Res 2002; 62:5069-75; PMID:12208763
   PubMed Web of Science ®Google Scholar
• De Palma M, Lewis CE. Macrophage regulation of tumor responses to anticancer therapies. Cancer Cell 2013; 23:277-86; PMID:23518347; http://dx.doi.org/10.1016/j.ccr.2013.02.013
   PubMed Web of Science ®Google Scholar
• Ziegler-Heitbrock L, Ancuta P, Crowe S, Dalod M, Grau V, Hart DN, Leenen PJ, Liu YJ, MacPherson G, Randolph GJ et al. Nomenclature of monocytes and dendritic cells in blood. Blood 2010; 116:e74-80; PMID:20628149; http://dx.doi.org/10.1182/blood-2010-02-258558
   PubMed Web of Science ®Google Scholar
• Wong KL, Tai JJ, Wong WC, Han H, Sem X, Yeap WH, Kourilsky P, Wong SC. Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets. Blood 2011; 118:e16-31; PMID:21653326; http://dx.doi.org/10.1182/blood-2010-12-326355
   PubMed Web of Science ®Google Scholar
• Zawada AM, Rogacev KS, Rotter B, Winter P, Marell RR, Fliser D, Heine GH. SuperSAGE evidence for CD14++CD16+ monocytes as a third monocyte subset. Blood 2011; 118:e50-61; PMID:21803849; http://dx.doi.org/10.1182/blood-2011-01-326827
   PubMed Web of Science ®Google Scholar
• Auffray C, Fogg D, Garfa M, Elain G, Join-Lambert O, Kayal S, Sarnacki S, Cumano A, Lauvau G, Geissmann F. Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science 2007; 317:666-70; PMID:17673663; http://dx.doi.org/10.1126/science.1142883
   PubMed Web of Science ®Google Scholar
• Cros J, Cagnard N, Woollard K, Patey N, Zhang SY, Senechal B, Puel A, Biswas SK, Moshous D, Picard C et al. Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors. Immunity 2010; 33:375-86; PMID:20832340; http://dx.doi.org/10.1016/j.immuni.2010.08.012
   PubMed Web of Science ®Google Scholar
• De Palma M, Venneri MA, Galli R, Sergi Sergi L, Politi LS, Sampaolesi M, Naldini L. Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell 2005; 8:211-26; PMID:16169466; http://dx.doi.org/10.1016/j.ccr.2005.08.002
   PubMed Web of Science ®Google Scholar
• Schauer D, Starlinger P, Reiter C, Jahn N, Zajc P, Buchberger E, Bachleitner-Hofmann T, Bergmann M, Stift A, Gruenberger T et al. Intermediate monocytes but not TIE2-expressing monocytes are a sensitive diagnostic indicator for colorectal cancer. PLoS One 2012; 7:e44450; PMID:22973451; http://dx.doi.org/10.1371/journal.pone.0044450
   PubMedGoogle Scholar
• Gabrusiewicz K, Liu D, Cortes-Santiago N, Hossain MB, Conrad CA, Aldape KD, Fuller GN, Marini FC, Alonso MM, Idoate MA et al. Anti-vascular endothelial growth factor therapy-induced glioma invasion is associated with accumulation of Tie2-expressing monocytes. Oncotarget 2014; 5:2208-20; PMID:24809734; http://dx.doi.org/10.18632/oncotarget.1893
   PubMed Web of Science ®Google Scholar
• Ibberson M, Bron S, Guex N, Faes-van't Hull E, Ifticene-Treboux A, Henry L, Lehr HA, Delaloye JF, Coukos G, Xenarios I et al. TIE-2 and VEGFR kinase activities drive immunosuppressive function of TIE-2-expressing monocytes in human breast tumors. Clin Cancer Res 2013; 19:3439-49; PMID:23649001; http://dx.doi.org/10.1158/1078-0432.CCR-12-3181
   PubMed Web of Science ®Google Scholar
• Hu L, Roth JM, Brooks P, Luty J, Karpatkin S. Thrombin up-regulates cathepsin D which enhances angiogenesis, growth, and metastasis. Cancer Res 2008; 68:4666-73; PMID:18559512; http://dx.doi.org/10.1158/0008-5472.CAN-07-6276
   PubMed Web of Science ®Google Scholar
• Rouzaut A, Lopez-Moratalla N, de Miguel C. Differential gene expression in the activation and maturation of human monocytes. Arch Biochem Biophys 2000; 374:153-60; PMID:10666293; http://dx.doi.org/10.1006/abbi.1999.1587
   PubMed Web of Science ®Google Scholar
• Sithu SD, English WR, Olson P, Krubasik D, Baker AH, Murphy G, D'Souza SE. Membrane-type 1-matrix metalloproteinase regulates intracellular adhesion molecule-1 (ICAM-1)-mediated monocyte transmigration. J Biol Chem 2007; 282:25010-9; PMID:17591781; http://dx.doi.org/10.1074/jbc.M611273200
   PubMed Web of Science ®Google Scholar
• Charo IF, Ransohoff RM. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 2006; 354:610-21; PMID:16467548; http://dx.doi.org/10.1056/NEJMra052723
   PubMed Web of Science ®Google Scholar
• Graves DT, Valente AJ. Monocyte chemotactic proteins from human tumor cells. Biochem Pharmacol 1991; 41:333-7; PMID:1994892; http://dx.doi.org/10.1016/0006-2952(91)90528-D
   PubMed Web of Science ®Google Scholar
• Rossol M, Kraus S, Pierer M, Baerwald C, Wagner U. The CD14(bright) CD16+ monocyte subset is expanded in rheumatoid arthritis and promotes expansion of the Th17 cell population. Arthritis Rheum 2012; 64:671-7; PMID:22006178; http://dx.doi.org/10.1002/art.33418
   PubMed Web of Science ®Google Scholar
• Lahiri R, Derwa Y, Bashir Z, Giles E, Torrance HD, Owen HC, O'Dwyer MJ, O'Brien A, Stagg AJ, Bhattacharya S et al. Systemic Inflammatory Response Syndrome After Major Abdominal Surgery Predicted by Early Upregulation of TLR4 and TLR5. Ann Surg 2016; 263:1028-37; PMID:26020106; http://dx.doi.org/10.1097/sla.0000000000001248
   PubMed Web of Science ®Google Scholar
• Sanford DE, Belt BA, Panni RZ, Mayer A, Deshpande AD, Carpenter D, Mitchem JB, Plambeck-Suess SM, Worley LA, Goetz BD et al. Inflammatory monocyte mobilization decreases patient survival in pancreatic cancer: a role for targeting the CCL2/CCR2 axis. Clin Cancer Res 2013; 19:3404-15; PMID:23653148; http://dx.doi.org/10.1158/1078-0432.CCR-13-0525
   PubMed Web of Science ®Google Scholar
• Matsubara T, Kanto T, Kuroda S, Yoshio S, Higashitani K, Kakita N, Miyazaki M, Sakakibara M, Hiramatsu N, Kasahara A et al. TIE2-expressing monocytes as a diagnostic marker for hepatocellular carcinoma correlates with angiogenesis. Hepatology 2013; 57:1416-25; PMID:22815256; http://dx.doi.org/10.1002/hep.25965
   PubMed Web of Science ®Google Scholar
• Shojaei F, Wu X, Malik AK, Zhong C, Baldwin ME, Schanz S, Fuh G, Gerber HP, Ferrara N. Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells. Nat Biotechnol 2007; 25:911-20; PMID:17664940; http://dx.doi.org/10.1038/nbt1323
   PubMed Web of Science ®Google Scholar
• Shojaei F, Wu X, Qu X, Kowanetz M, Yu L, Tan M, Meng YG, Ferrara N. G-CSF-initiated myeloid cell mobilization and angiogenesis mediate tumor refractoriness to anti-VEGF therapy in mouse models. Proc Natl Acad Sci U S A 2009; 106:6742-7; PMID:19346489; http://dx.doi.org/10.1073/pnas.0902280106
   PubMed Web of Science ®Google Scholar
• Schauer D, Starlinger P, Zajc P, Alidzanovic L, Maier T, Buchberger E, Pop L, Gruenberger B, Gruenberger T, Brostjan C. Monocytes with angiogenic potential are selectively induced by liver resection and accumulate near the site of liver regeneration. BMC Immunol 2014; 15:50; PMID:25359527; http://dx.doi.org/10.1186/s12865-014-0050-3
   PubMed Web of Science ®Google Scholar
• Buchberger E, El Harchi M, Payrhuber D, Zommer A, Schauer D, Simonitsch-Klupp I, Bilban M, Brostjan C. Overexpression of the transcriptional repressor complex BCL-6/BCoR leads to nuclear aggregates distinct from classical aggresomes. PLoS One 2013; 8:e76845; PMID:24146931; http://dx.doi.org/10.1371/journal.pone.0076845
   PubMedGoogle Scholar
• Moll HP, Freudenthaler H, Zommer A, Buchberger E, Brostjan C. Neutralizing type I IFN antibodies trigger an IFN-like response in endothelial cells. J Immunol 2008; 180:5250-6; PMID:18390705; http://dx.doi.org/10.4049/jimmunol.180.8.5250
   PubMed Web of Science ®Google Scholar